fda tirzepatide compound update Compounded Tirzepatide: Legal & Safe 2026 FDA Moves to Restrict Mass-Marketed

Plaintiffs who did not want to be included in the settlement or missed the deadline to provide necessary documents for the settlement had to write to the judge and tell her why their cases should not be dismissed

I was struggling to lose weight no matter how much I worked out

For comparison: Participants taking 2.4 mg lost around 17% of their starting body weight Participants receiving a placebo lost around 23% Participants using the new 7.2mg strength reported losing 21% of their starting weight

In one study, semaglutide 2.4 mg (Wegovy/Ozempic) plus lifestyle intervention produced an average weight loss of 14.9% of body weight over 68 weeks [14, 13]